Pricing Log in Create free account

4D pharma PLC Sponsored ADR (LBPS) vs NanoViricides, Inc. (NNVC)

4D pharma PLC Sponsored ADR and NanoViricides, Inc. are both Biotechnology companies. 4D pharma PLC Sponsored ADR and NanoViricides, Inc. are of similar size ($37.2M and $35.0M). NanoViricides, Inc. has the higher net margin (0.00% vs −2,010.9%) and the lower return on invested capital (−88.2% vs 0.00%). Across the 12 metrics below, NanoViricides, Inc. leads on 8 and 4D pharma PLC Sponsored ADR on 4.

Valuation

Metric LBPS NNVC Biotechnology median
P/E n/m n/m 8.50
P/S 211.23 n/m 9.71
P/B 9.49 3.21 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA — n/m 0.64
EV/Sales — n/m 9.21
Earnings yield (40.76%) (28.89%) (33.15%)
Free cash flow yield (30.32%) (27.93%) (25.50%)

Profitability

Metric LBPS NNVC Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (2,010.89%) 0.00% 0.00%
Free cash flow margin (3,283.80%) 0.00% 0.00%
Return on equity (155.83%) (101.46%) (56.36%)
Return on assets (77.95%) (87.91%) (48.04%)
Return on invested capital 0.00% (88.16%) 0.00%

Growth

Metric LBPS NNVC Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 35.04% 35.38% 30.26%
Revenue growth, 5-year CAGR 21.70% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LBPS NNVC Biotechnology median
Debt to equity 0.43 0.00 0.00
Current ratio 5.21 2.66 4.72
Net debt to EBITDA 0.23 0.36 0.96

Dividend

Metric LBPS NNVC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LBPS NNVC Biotechnology median
Market cap 37.19m 34.97m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack